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Background: Ankylosing spondylitis (AS) is an autoimmune disorder characterized by inflammation of the spine
and large joints. Fatigue is a common symptom that many AS patients find significantly impacts their health-related
quality of life. The Worst Fatigue – Numeric Rating Scale (WF-NRS) assesses the severity of this symptom during the
previous 24-hour period. The objective of this study was to perform qualitative research to support the development
and content validity of the WF-NRS.
Methods: Patients with AS were recruited from clinical sites in the U.S. for a qualitative study which first entailed
concept elicitation interviews to gain understanding of the patients’ experience with AS and fatigue. Subsequently,
cognitive debriefing interviews were undertaken to assess the understandability, clarity, and appropriateness from the
patient’s perspective, of the content of a measure of fatigue severity.
Results: Thirteen patients with AS participated in concept elicitation interviews and cognitive debriefing of the Brief
Fatigue Inventory (BFI) fatigue severity subscale. The WF-NRS was developed from the worst fatigue item of the BFI as
patients generally reported it to be understandable and covered an important concept, the completion instructions
were modified, but the response scale remained as it was familiar and readily completed, and the recall period was
appropriate.
Conclusions: Patient responses resulted in the development of and supported the content validity of the WF-NRS.
Further quantitative evaluation of the WF-NRS is warranted in order to assess its psychometric properties and confirm
its usefulness as a clinical trial tool.
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Ankylosing spondylitis (AS) is an autoimmune disorder
characterized by inflammation of the spine and large
joints. Prevalence rates for AS have been estimated to be
0.2 – 1.2% [1], and historically males have been found to
be more predominantly affected than females [2,3].
However, this historical precedence may have contrib-
uted to gender biased research and under-diagnosis in
women [4]. It is a chronic condition of young adults that* Correspondence: eheredia@lilly.com
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reproduction in any medium, provided the orcommonly develops in the third decade of life [1]. Com-
mon symptoms include joint pain, fatigue, low-grade
fever, loss of appetite, and eye inflammation [3]. There is
wide inter-individual variability in bearing the burden of
AS as some patients experience minor disabilities while
others may have severe deformities of the spine. Aspects
such as reduction in physical function, withdrawal from
activities (including employment), and impairment in
quality of life, comprise a significant portion of the dis-
ease burden [5].
Although there is variability in the burden of AS,
many patients experience fatigue as part of their disease,l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[6]. Furthermore, fatigue has been found to be one of
the key symptoms that can significantly impact health-
related quality of life [7], and patients with AS have
reported that fatigue has impacted their social life, rela-
tionships, and work [8]. For this reason, researchers have
called for both a comprehensive assessment of fatigue as
part of routine clinical practice in patients with AS and
the development of treatment programs directed at alle-
viating the fatigue that often accompanies AS [8].
The primary objectives of the qualitative research pre-
sented here are to describe the patient’s experience with
fatigue with respect to their AS and to evaluate the con-
tent validity of a measure of fatigue severity for these pa-
tients. Concept elicitation interviews were undertaken to
gain insights into patients’ with AS perceptions of the
symptoms of their condition, especially fatigue, the im-
portance of those symptoms, and the impacts of AS on
patients’ lives. Key insights gleaned from these inter-
views demonstrated the importance of fatigue in AS and
the need for clinical research to capture symptom sever-
ity as a means of demonstrating treatment benefit.
Subsequently this research led to the development of the
Worst Fatigue Numeric Rating Scale (WF-NRS), a
single-item patient reported outcome (PRO) measure
that assesses the level of worst fatigue severity experi-
enced by the patient during the previous 24 hours. This
manuscript presents results from qualitative analyses of
the interview data to support conclusions regarding the
development and usefulness of the WF-NRS for the as-




This was a cross-sectional, qualitative study involving
one-on-one, in-person interviews. Participants were
identified and recruited through three clinical sites in
the U.S. with the sample size determined by saturation.
Specifically, information “saturation” refers to the point
in the interviewing process when interviews are no lon-
ger yielding new information and the researcher can feel
confident that all important concepts related to the re-
search question have been identified [9].
Eligibility criteria and recruitment
Ambulatory patients with AS aged eighteen years or
older were eligible for this study. Original inclusion cri-
teria required an established AS diagnosis (modified
New York Criteria) for at least twelve weeks and a Bath
Ankylosing Spondylitis Disease Activity Index (BASDAI)
score ≥ 4 and back pain score ≥ 4 on a 10-cm visual
analogue scale (VAS). The back pain score was based
upon the average of overall spinal pain and nocturnalspinal pain VAS scores for the past week. The inclusion
criteria were modified after recruiting sites reported that
some of the information necessary to determine eligibil-
ity under the original criteria was not readily available as
it was not routinely collected or assessed in clinical prac-
tice. Specifically, the revised criteria no longer required a
diagnosis based on the modified New York Criteria or a
BASDAI score of ≥ 4; however, clinical confirmation of
diagnosis via patient medical records was retained as a
requirement. The revised criteria were adopted after re-
cruitment of 3 participants (1 male) in order to enhance
recruitment and pragmatically reflect clinical routines.
Patients with complete ankylosis of the spine were not
eligible.
Site staff reviewed medical charts and/or electronic pa-
tient databases in order to identify eligible participants
and subsequently contacted these AS patients for further
screening and possible enrollment. Institutional Review
Board (IRB) approval was obtained from the Independ-
ent Investigational Review Board Inc. (Plantation,
Florida, USA) prior to recruitment of participants.
Study procedures
Before beginning the interview, the participant reviewed
and signed an IRB approved consent form. Approxi-
mately one-hour long interviews were then conducted
by a trained researcher who followed a semi-structured
interview guide (Table 1). The first part of the interview
was designed to elicit information from patients about
the symptoms and impacts of AS. Participants were
asked open-ended questions about their experiences
with AS (e.g., “What is it like to have AS?”) and the
interviewer followed up with probing questions as ne-
cessary. Then the Brief Fatigue Inventory (BFI) [10] was
administered to patients after which cognitive debriefing
interviews were conducted to assess the clarity, rele-
vance, and comprehensiveness of that instrument, spe-
cifically the fatigue severity subscale. The BFI is a 9-item
measure assessing fatigue severity and interference in
daily life . One item from the severity subscale asks the
respondent to “Please rate your fatigue (weariness, tired-
ness) by circling the one number that best describes
your WORST level of fatigue during the past 24 hours”.
Responses are on an 11-point numeric rating scale with
anchors at 0 (No fatigue) and 10 (As bad as you can
imagine).
All interview sessions were digitally audio-recorded
with the participant’s permission and subsequently tran-
scribed for analysis purposes.
Analyses
A thematic analytic approach was used to summarize
and evaluate the data from the interviews [11]. Coding
was performed using MaxQDA 10 [12], a text analysis
Table 1 Example of questions in the semi-structured discussion guide
Topic Example questions for each symptom mentioned
Description What is ita like? Can you describe that for me?
Frequency How often does it happen? Does it vary? How long does it last? Does that change from day-to-day
or throughout the day?
Severity How severe is it? Does the severity change from day to day or throughout the day? What is it like
when it’s at its worst? What is it like when it’s at its mildest? Does anything make it better?
Does anything make it worse?
Emotional Impact Does ankylosing spondylitis affect you emotionally? If so, how?
Impact on activities of daily living Does ankylosing spondylitis affect your everyday activities? If so, how? Does ankylosing spondylitis
affect what you do? Do you ever avoid activities because of ankylosing spondylitis?
Impact on leisure/social/family activities Does ankylosing spondylitis affect your social activities? Does ankylosing spondylitis affect your relationships?
aInterviewers used the term for each symptom spontaneously reported by participant.
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data and allow for a thorough exploration of themes and
concepts emerging from the data. After a process of in-
dependent coding of two transcripts by two team mem-
bers, the team discussed and reached consensus on a
codebook, which was then used by one researcher to
code all transcripts.
Analysis of the cognitive debriefing portion of the in-
terviews was on a question-by-question basis. The ana-
lysis focused on identifying any issues with the instrument
with respect to clarity, interpretation, relevance, and com-
prehensiveness of the items, response options, instruc-
tions, and recall period. Descriptive statistics (e.g., mean,
frequency) were used to characterize the demographics of
the sample of participants.
Results
A total of thirteen participants completed interviews.
After the first three interviews, revisions to the inclusion
and exclusion criteria (noted above) were made to en-
hance recruitment and the next ten participants were re-
cruited under the revised criteria. Table 2 shows the
sociodemographic characteristics of the sample. There
were eight females and five males, and the mean (SD)
age was 47 (13.4) years. The majority (N = 10) of partici-
pants rated their current level of AS as “moderate” and
the remaining 3 participants rated their current AS level
as “severe”. For the last ten participants (i.e., those re-
cruited after the change in eligibility criteria and for
whom data are available), the mean spinal pain NRS
scores were: 6.0 (SD 1.2) for overall pain and 6.2 (SD
1.8) for nocturnal pain. For the entire sample, the aver-
age time since AS diagnosis was 13 years, with a mini-
mum of 1 year and a maximum of 35 years. There were
no new concepts reported or codes applied after the 7th
interview transcript, which suggests that saturation was
attained by the eighth interview. As a means to gather a
more in-depth understanding of the concept(s) being
studied, we continued to interview 5 participants beyond
the saturation point.Concept elicitation
During concept elicitation interviews, participants re-
ported being significantly affected by their AS with
symptoms such as pain, stiffness, and fatigue/tiredness/
less energy. Common impacts reported by participants
associated with their condition included sleep difficul-
ties, physical deformity, decreased mobility and activ-
ities, change in personality, frustration, realization of
mortality, and uncertainty about the future. Exemplary
quotes from the concept elicitation interviews are pre-
sented in Table 3.
Description of fatigue
All thirteen participants had experienced fatigue associ-
ated with AS, although one participant was less affected
at the time of the interview and another reported not
currently experiencing fatigue. Three of the participants
spontaneously used the term ‘fatigue’. Other related
terms used spontaneously, or words that were supplied
in initial responses to the interviewer’s use of the term
fatigue, included: tired, exhausted, feeling worn out or
wiped out, (lack of ) energy, run down, hard to concen-
trate or focus, slow motion, needing to rest, and falling
asleep. Some participants reported feeling that although
they did things at the same pace as before the onset of
AS, they had less energy and consequently ran out of en-
ergy sooner. Others described this concept in terms of
doing things more slowly, taking longer than usual to do
things, or of being in slow motion.
Clarity and interpretation of the construct of fatigue
All participants understood the term ‘fatigue’. Partici-
pants reported that ‘fatigue’ and ‘tired’ meant the same
thing to them. One participant noted that fatigue meant
being ‘really tired’ while others said they felt ‘exhausted’.
Participants interpreted fatigue in terms of a lack of en-
ergy, running out of energy or completing tasks but
without ‘zest’. Some participant’s comments suggested a
mental component to the concept of fatigue and, in par-
ticular, noted being ‘too tired to think’.
Table 2 Sociodemographic and Clinical Characteristics
Characteristic AS patients
(N = 13)
N or Mean % or SD




Highest Level of Education Completed
High School/GED 3 23%
Some College/Associates Degree 7 54%
College Degree 1 8%
Graduate Degree 2 15%
Current Employment Status
Employed Full-Time 4 31%
Employed Part-Time 1 8%











Years Since Initial Diagnosis of AS (mean; SD) 13.0 12.3
Current Level of AS
Moderate 10 77%
Severe 3 23%
NRS Spinal Pain Scoresa
Total pain 6.0 1.2
Nocturnal pain 6.2 1.8
aBased on final 10 participants for whom data is available.
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Participants reported that fatigue varied over the course
of the day, with several individuals reporting extreme fa-
tigue at the end of the day. Mornings were reported to
be somewhat better with respect to fatigue, with this im-
provement sometimes attributed to having rested during
the night. Some patients, however, woke up feeling tired.
It might take them considerable time to ‘get moving’ in
the morning, but once moving, their fatigue and pain
levels seemed to decrease. For some participants, fatigue
severity increased over the course of the week, and they
used the weekend to rest and ‘charge their battery’.Fatigue and pain
Pain was another key symptom of AS, and all thirteen
participants reported experiencing pain. There appeared
to be a complex relationship between fatigue and pain.
For instance, when asked about fatigue, participants
would often respond by talking about their pain. How-
ever, it was not possible to identify either a consensus on
the participants’ perceived association between fatigue
and pain or a causal relationship between the two. Some
participants reported being ‘tired from the pain’, suggest-
ing that the experience of pain was physically and/or
emotionally tiring. Conversely, others reported that
when they were tired, more pain was experienced. Eight
participants reported experiencing disturbed sleep be-
cause of pain during the night, and the tiredness in the
morning was seen as result of this pain.
Other factors associated with fatigue
Some participants reported feeling depressed. The expe-
riences of both pain and fatigue could be related to, or
exacerbated by, feelings of depression. Other sleep dis-
turbances (i.e., those not related to pain) were also re-
ported as contributing to waking up tired. Participants
reported that resting and taking naps could help to re-
duce fatigue.
Cognitive debriefing
Overall, the cognitive debriefing interviews revealed that
participants with AS interpreted the items of the BFI in
a consistent manner and, based on the judgment of the
study team, as intended. Table 4 presents exemplary
quotes from the study participants during the cognitive
debriefing interviews.
Understandability
In general, participants found the worst fatigue item of
the BFI to be clear and easy to understand. They under-
stood that the item was asking them to rate the severity
of their fatigue at its worst level over the previous 24
hour period. However, two issues related to comprehen-
sion were reported during the interviews. First, one par-
ticipant noted some confusion with the wording of the
item since both ‘best’ and ‘worst’ appeared together in
the item (i.e., ‘choose the one number that best describes
your WORST level of fatigue’). Second, one participant
was unfamiliar with the term “weariness”, which appears
in parentheses next to the term “fatigue” to further de-
fine it. Furthermore, no participant spontaneously used
the term ‘weariness’ or feeling ‘weary’ during the concept
elicitation part of the interviews. Three participants used
the term only after seeing it in the BFI. The remaining
participants in the sample either did not use the term at
all or referred to a symptom that ‘wears on you’, or
‘wears me out’, or ‘wears me down’.
Table 3 Descriptions of fatigue
Exemplary participant quotes from concept elicitation interviews
Topic Quote
Description of fatigue “I do things at the same pace, but I run out of energy more quickly, which means I do a lot less things. Whereas in
the beginning of the day I might be able to grab some laundry on the way and drop something off in this room
and then, you know, stop and do this and stop and do that. By the end of the day it’s – the tasks are chosen
carefully and they’re completed with no zest, no, it’s just done. …there’s a pretty moderate level of fatigue that I
deal with. I used to have energy to go from morning till night and get everything done. Now by 5 or 6 pm I’m –
at 5 or 6pm I’m basically useless…”
“… feel tired all the time.”
“… I feel like my life is in slow motion because I have to do everything so slow and take rest times.”
“Once Saturday gets here, I am just wiped out. … I don’t do too much of anything on Saturdays. I mean, I just,
I can’t. I sleep. …”
“I’ve been feeling run down.”
“It’s hard for me to concentrate; it’s hard for me to focus.”
Clarity and interpretation
of concept of fatigue
“It’s a feeling of I’m so tired that I cannot function or anything or even think and it’s hard because there are
things that I need to do.”
(Response to probe regarding ‘fatigue’ and ‘tired’). “I feel like the same, almost like the same.”
“I think fatigue, sometimes – well, fatigue to me sounds like it’s when you’re really tired, really, you know,
really need to sit down or whatever.”
“Oh, I’m always exhausted.”
“Just – you just feel like you didn’t get a good night’s sleep and that if you have to lay down and take – to take
naps, you know, to see if that would help and, nine times out of ten, I wake up just the same as I went to sleep. So it’s
I can’t – I don’t really relax, I don’t think, really good ‘cause I’m – you have to move around to get comfortable.”
Frequency and duration “… the day when I feel more rested, on Monday, because as I say I feel like I charged my battery all weekend
so I'm ready to work on Monday and as the week go on, like Tuesday morning a little bit more tired than
Monday and then Wednesday, Thursday, Friday I'll finally – the last day of work, you know.”
“I’m better in the mornings as far as being fatigued. I don’t feel fatigued when I get up in the mornings. I feel fine.”
Fatigue and pain “But then, like I said, I don't know the difference any more. Like, I can't remember the difference of what it's like
to not be in pain, what it's like to not actually have fatigue. So, I don't know, honestly.”
“I think it’s that the pain kind of wears you down and I think it’s a cumulative thing.”
“Well, it's tough because barely I work my shift. I start early in the morning and when I done – like right now I just get
off from work at 2.. as soon as I get off from work I get at my home and I do nothing 'cause I'm tired, I got pain all
over my body. So, I don't want to do nothing more. I just – all I think is just get home and rest. That's all I want to
know. I just want to rest.”




“Yes, that’s a major thing. I – naps are good. I take naps all the time.”
“.. close my eyes, just sit there and let my body regenerate.”
“… I’ve been trying to get back on the treadmill … I was able to walk two miles last night and it took me about
38 minutes, which is not – I normally can go a little faster than that. .. I was very tired, but I felt better afterwards, …”
“… well, to me, the reason it’s not mentioned is that everybody gets tired. It’s something everybody complains
about. Tired for one reason or another. And if you talk to someone else, like I talk to my friends about being tired,
and then they’ll tell you how tired they are.”
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The response scale used in the worst fatigue item was
generally well understood. Some participants found the
eleven-point numeric rating scale to be similar to other
scales they had used previously. There was one partici-
pant who initially answered with a ‘2’, but when the
interviewer asked how she had decided upon her answer,
the respondent realized she had interpreted the direction
of the scale incorrectly and corrected her response to an‘8’. Aside from that oversight, no other difficulties with
the response scale were reported, and the other partici-
pants found the scale to be clear and appropriate.
Recall period
The recall period of the worst fatigue item was consid-
ered appropriate, and participants appeared to have no
difficulty recalling their experiences with fatigue over the
past 24 hours. While most participants used the recall
Table 4 Content Validity of the WF-NRS
Exemplary participant quotes from cognitive debriefing interviews
Topic Quote
Understandability If I’d had any worse in the last 24 hours, which last night was one of those nights that wasn’t a good night and I think I
was up four or five times, you know?
“ … there’s just that little period once I’ve been home for a half hour, 45 minutes and then after I’ve been home for, you
know, over an hour, it’s just – that’s when I’m the most tired and then I kind of get my second wind… So I’d say it’s just
that period after work where I move up to about a six.”
“So if you want to ask me what my worst level of fatigue is, maybe – again, I don’t – these were just all kind of – I always
think if they’re trying to get a trick question out of me, so “Best describes your worst level of fatigue during the past” –
I don’t know. That worst kind of throws me off by that. Because isn’t fatigue bad anyways, no matter how you look at it?
Response scale “How did I decide? Wait a minute. No fatigue. Oh, I meant to do it the other way. I really meant the other way. So that
really should have been at this end…Oh, ok. I’m sorry I misread that one. I would think around a 7. It’s, you know, it’s as
bad as you can imagine. I would think maybe an 8. Can I change it?
Recall period “… Depending on what the person is doing every 24 hours – at least for me every 24 hours is different… so I
understand that you’ve got to put a time on the stuff, but the last 24 hours for me is different than the middle of the
week 24 hours of the last week.”
“Yeah, I think that’s, kind of – I probably should do one of these every day, that way I would know exactly how I feel
every day, you know, because it just makes you realize just how tired you are or how it affects your daily life, you know,
so, very interesting.”
“For me, I – 24 hours, it depends on what – for me, I would look at a week, because I think during the course of a week
you will see – there’s a – and I don’t know how everybody else is, but I just know during the course of a week there
could be a week that’s good, there could be a week that has a day or so that’s not so good, you know, and that’s just…:
I just think you’ll get a bigger picture by looking at it over a course of a week.”
Possible mediating factors
and adjustments
“I haven’t felt like I’ve rested well.”
“That was just I pretty much wore myself out, just of the things that I did and the fact that I think my body doesn’t work
as fast, you know, there’s always the pain and the stiffness, so therefore, to me, you know, it’s – that causes the fatigue to
really, you know, get worse, so…I just thought to myself that that’s just how I felt, that I just really, you know – I really
don’t know how to explain it. It’s not that I just want to you know, lie down and sleep all the time. It’s just that you just
feel like you never – with the stiffness and the pain it just never gives you a feeling of you’ve really had a good rest.
You’ve really had a good, you know, it’s just really hard to, and that’s why I put eight because that’s what I felt, you
know, I haven’t felt like I’ve rested well, you know, so, I don’t know.”
“Now 10 is almost like crawling into bed and, you know, and listening to something and having a difficult time just filtering
and, you know, and just – that’s severe. And what’s amazing is that – I don’t want you to think that there is, you know,
it’s – it’s not a mental problem. It’s like you’re so fatigued that it’s just difficult to process the info, you know, I dunno.”
“When my mother came into my room I actually snapped at her, you know? I didn't mean to and I felt really bad.”
“… because you do kind of adjust ‘cause in your mind you do think, what – and that’s why, I guess, I go back to that
day that I say that was my worst day because in my mind I can kind of know what I’ve done …”
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dence that one patient may have used a longer recall
period in responding, as when asked to define the item,
the participant described fatigue experienced a few days
prior. In addition, some participants suggested increas-
ing the recall period to three days or a week because
they were concerned that a 24 hour recall period might
not provide an accurate picture of their fatigue, espe-
cially given the variability of this symptom.
Possible mediating factors
During the cognitive debriefing interviews, the replies of
some of the participants indicated that they had taken
other factors into account when selecting the response
that reflected their worst fatigue severity. Some partici-
pants made an initial rating, as described above, and
then adjusted the reported score if they could identify aspecific reason for fatigue severity. For instance, partici-
pants reported adjusting a rating downward if there were
circumstances that might explain their fatigue, such as if
they had been particularly active. Other reasons included
the effort required to do tasks, rest and/or sleep, lack of
energy, irritability, cognitive impairment, and pain.
Recommended changes
Based on the participants’ comments during the inter-
views, several recommendations for modification were
proposed for clarifying the verbiage of the worst fatigue
item of the BFI and, also, for its administration in
clinical trials, which led to the development of the WF-
NRS “Please rate your fatigue (feeling tired or worn out)
by circling the one number that best describes your
WORST level of fatigue during the past 24 hours”. Re-
sponses are on an 11-point numeric rating scale with
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imagine).
First, in order to enhance understandability, the word
‘best’ was removed from the instruction component of
the item. Second, the term ‘weariness’, which was used
to elaborate on the term ‘fatigue’, was replaced by the
term ‘worn out’ which seemed to resonate with a larger
number of participants.
Third, in order to better reflect the variability of fatigue
severity found in the AS population, it was recommended
that the fatigue severity measure be administered as a
daily diary in the clinical trial setting. Finally, a last recom-
mendation was to include in the AS clinical trials items or
PRO tools that would capture potential covariates of
fatigue, such as sleep disturbance, physical activity level,
and pain.
Discussion
In this study, we intended to capture participant’s ex-
perience with having AS. Many were young adults (the
youngest was 26 years old) or had lived very active lives
(the oldest was a 76-year old competitive triathlete) prior
to disease onset. Fatigue and pain were often experi-
enced at extreme levels, and the symptoms affected all
areas of participants’ lives: mobility, work, career aspira-
tions, social activities, relationships, and emotional well-
being. Although participants typically mentioned chronic,
and sometimes excruciating, pain when first asked about
their experience of AS, when probed about fatigue, they
responded with ‘Oh yes, very much so’ and ‘Oh, I’m always
exhausted’. One participant suggested that one possible
explanation for not reporting fatigue spontaneously could
be the ‘normalization’ of the phenomenon by themselves
(i.e., feeling fatigued becomes customary) or others (i.e.,
‘everybody gets tired’), and hence participants’ omission to
report this. Fatigue severity was reported to be highly vari-
able from day-to-day as well as throughout the day, with
the evening often cited as the time of worst fatigue sever-
ity. Participants mentioned a number of factors influen-
cing fatigue severity, including pain, sleep disturbances
(that may be related to pain), exercise or activity, and feel-
ing depressed.
Results from the concept elicitation interviews also in-
dicated that all participants clearly understood the term
‘fatigue’ and some of them used it spontaneously when
describing their condition. It is possible that individuals
with AS quickly learn the term because it is used by doc-
tors and other patients when discussing the condition.
While participants also used other terms and phrases to
describe fatigue, such as tiredness, feeling worn out,
exhausted, needing to rest, slowed down, etc., the term
‘fatigue’ resonated with participants and was considered
clear and appropriate for describing how AS makes them
feel.In summary, the concept elicitation interviews con-
firmed that fatigue was a key symptom of AS. All partici-
pants reported experiencing fatigue at some point during
their illness, with all but one participant currently experi-
encing fatigue. Along with pain, fatigue was considered a
bothersome symptom of AS, with one participant report-
ing that fatigue was the most bothersome symptom.
Although there have been a large number of scales de-
veloped with the intent of measuring fatigue [13], the
WF-NRS has a number of characteristics that distinguish
it from the alternatives. First, the WF-NRS was devel-
oped based on qualitative input (concept elicitation in-
terviews and cognitive debriefing of the BFI) from an AS
population ensuring the assessment of an important and
relevant aspect of fatigue severity. This type of patient
input is a key aspect for establishing content validity as
the fatigue experience may differ across patient popula-
tions and scales developed for one condition may not be
appropriate for use in another. Many of the existing fa-
tigue scales were developed in patient populations other
than AS, such as those with cancer [10,14,15], chronic fa-
tigue syndrome[16-18], multiple sclerosis [19-21], rheu-
matoid arthritis [22], or general medical patients [23,24].
To the best of our knowledge, content validity in AS has
not been established for most of these instruments. Sec-
ond, the WF-NRS is a single-item, unidimensional instru-
ment inquiring about the worst level of fatigue in a 24
hour period as a measure of fatigue severity, which the in-
terviews revealed to be relevant and understandable in pa-
tients with AS. Having respondents answer queries based
on their worst experience is consistent with recommenda-
tions from PRO development guidelines for using appro-
priate methods and techniques to enhance the validity
and reliability of self-reported data [25]. In contrast, the
other measures listed above are all multiple-item tools
that assess fatigue as either a unidimensional [10,14,16,19]
or a multidimensional [15,17,18,20-24] construct. The
brevity of the WF-NRS may make it particularly suitable
for use in clinical trials with a patient population that
suffers from fatigue, especially if the trial subjects will be
expected to complete a battery of other assessment instru-
ments. Finally, the 24-hour recall period appears to be
short enough that patients will not have difficulties in ac-
curately completing the instrument. The study partici-
pants suggested that fatigue severity was periodic and
therefore other recall periods, such as “at the present
time”, may not capture clinical peaks. Additionally, cap-
turing the worst level of fatigue in a short timeframe does
not require the patient to average his or her symptom se-
verity over time. Patient responses that rely on memory
based on long periods of time, or require the responder to
average their response, may introduce recall bias [25].
Moreover, incorporating the WF-NRS in a daily diary may
help ensure that day-to-day variability in worst fatigue
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cerns that just one assessment may not accurately
characterize their fatigue severity. The addition of a clin-
ical outcome assessment tool to capture cognitive impair-
ment should also be considered as participant comments
suggest a mental component of fatigue presenting as a
consequence of AS.
A limitation of the study may be that the small sample
size allowed participant’s input to be obtained from only
three clinical sites, although they were located in separ-
ate regions of the country. However, the intention of
sampling for qualitative research for the development of
a patient-reported outcome measure is not to obtain a
representative sample of the epidemiologic profile of the
patient population but rather to ensure an enriched di-
versity in patient and disease characteristics, and the dis-
tribution of variables indicated a diverse sample with
respect to sociodemographic characteristics was ob-
tained. Also, the recruited participants did not include
AS patients with a mild level of severity. While the re-
sults of this initial qualitative study of fatigue in AS pa-
tients were promising, further quantitative research is
indicated. In particular, additional research with the WF-
NRS is required in order to assess its test-retest reliabil-
ity; to examine its concurrent, discriminative, and
construct validity; and to determine its sensitivity to
change. Additionally, the translatability of the WF-NRS
into other languages and cultures would also need to be
examined before using the instrument in global clinical
trials. Nonetheless, the interviews completed with pa-
tients with AS in the present study led to the develop-
ment of the WF-NRS and ensured that the content was
relevant to the AS population and the clarity, interpret-
ation (as intended per judgement of the study team), re-
sponse scale, and recall period were all appropriate.
Conclusion
The reported prevalence and bothersomeness of fatigue
supports the importance of assessing the concept of
worst fatigue severity in patients with AS to capture
treatment benefit(s) in a trial setting. Results of concept
elicitation interviews and cognitive debriefing of the BFI
fatigue severity subscale support the development and
content validity of the Worst Fatigue – Numeric Rating
Scale to assess that aspect of fatigue. Additional research
is warranted to further evaluate the psychometric meas-
urement properties of the instrument, including con-
struct validity, reliability, and sensitivity to change, and,
thereby, support its use in clinical trials.
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